COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67

E Richardsen, RD Uglehus, J Due, C Busch… - Cancer …, 2010 - Elsevier
Background: The immune modulating molecules cyclooxygenase-2 (COX-2), transforming
growth factor-β (TGF-β) and interleukin-10 (IL-10) have regulatory roles in cancer …
被引用次数：107 相关文章

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival: A comparison study between COX-2, TGF-beta, IL-10 and Ki67

E Richardsen, RD Uglehus, J Due, C Busch… - Cancer …, 2010 - swepub.kb.se
BACKGROUND: The immune modulating molecules cyclooxygenase-2 (COX-2),
transforming growth factor-beta (TGF-beta) and interleukin-10 (IL-10) have regulatory roles …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67

E Richardsen, RD Uglehus, J Due, C Busch… - Cancer …, 2010 - hero.epa.gov
BACKGROUND: The immune modulating molecules cyclooxygenase-2 (COX-2),
transforming growth factor-beta (TGF-beta) and interleukin-10 (IL-10) have regulatory roles …

[引用][C] COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and …

E RICHARDSEN - Cancer Epidemiol., 2010 - cir.nii.ac.jp
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict
survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 | CiNii Research …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67.

E Richardsen, RD Uglehus, J Due, C Busch… - 2010 - cabidigitallibrary.org
Background: The immune modulating molecules cyclooxygenase-2 (COX-2), transforming
growth factor-β (TGF-β) and interleukin-10 (IL-10) have regulatory roles in cancer …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-[beta], IL-10 and Ki67

E Richardsen, RD Uglehus, J Due… - Cancer …, 2010 - search.proquest.com
Background: The immune modulating molecules cyclooxygenase-2 (COX-2), transforming
growth factor-β (TGF-β) and interleukin-10 (IL-10) have regulatory roles in cancer …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67

E Richardsen, RD Uglehus, J Due… - Cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The immune modulating molecules cyclooxygenase-2 (COX-2), transforming
growth factor-beta (TGF-beta) and interleukin-10 (IL-10) have regulatory roles in cancer …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.

E Richardsen, RD Uglehus, J Due, C Busch… - Cancer …, 2010 - europepmc.org
Background The immune modulating molecules cyclooxygenase-2 (COX-2), transforming
growth factor-beta (TGF-beta) and interleukin-10 (IL-10) have regulatory roles in cancer …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival: A comparison study between COX-2, TGF-beta, IL-10 and Ki67

E Richardsen, RD Uglehus, J Due, C Busch… - Cancer …, 2010 - diva-portal.org
BACKGROUND: The immune modulating molecules cyclooxygenase-2 (COX-2),
transforming growth factor-beta (TGF-beta) and interleukin-10 (IL-10) have regulatory roles …

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67

E Richardsen, RD Uglehus, J Due, C Busch… - Cancer …, 2010 - infona.pl
Background: The immune modulating molecules cyclooxygenase-2 (COX-2), transforming
growth factor-β (TGF-β) and interleukin-10 (IL-10) have regulatory roles in cancer …